Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer

BACKGROUND: Recent studies have shown that multidrug resistance may be induced by the high stemness of cancer cells. Following prolonged chemotherapy, MDR protein 1 (MDR1) and CD133 increase in CRC, but the relationship between them is unclear. METHODS: The relationship between MDR and CSC propertie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zeting, Liang, Xin, Zhan, Yueping, Wang, Ziyuan, Xu, Jian, Qiu, Yanyan, Wang, Jie, Cao, Yijun, Le, Van-Minh, Ly, Hai-Trieu, Xu, Jianhua, Li, Wei, Yin, Peihao, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188877/
https://www.ncbi.nlm.nih.gov/pubmed/32203206
http://dx.doi.org/10.1038/s41416-020-0783-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188877/
https://www.ncbi.nlm.nih.gov/pubmed/32203206
http://dx.doi.org/10.1038/s41416-020-0783-0

Ejemplares similares